Results 171 to 180 of about 1,913,005 (248)

Oral malignant melanoma. [PDF]

J Oral Maxillofac Pathol, 2020
Ashok S, Damera S, Ganesh S, Karri R.
europepmc   +1 more source

Incidence, severity and potential pathomechanism of immune‐related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapy

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Pruritus is a frequent cutaneous immune‐related adverse event (irAE) associated with immune checkpoint inhibitors (ICI), impacting patients' quality of life. This study investigates the incidence, severity and management of pruritus in melanoma patients treated with ICI.
Andrea Roggo, Nikolina Ivanovic, Patrick Turko, Lukas Kraehenbuehl, Mitchell Levesque, Reinhard Dummer, Barbara Meier‐Schiesser   +6 more
wiley   +1 more source

Tracheal metastasis from primary oral malignant melanoma: A case report. [PDF]

Medicine (Baltimore)
Liu Y, Guo W, Zhang S, Bian C.
europepmc   +1 more source

Assessing patient perception following outpatient dermatological surgical procedures

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Despite receiving similar information about outpatient dermatologic surgical procedures, some patients still hold misconceptions about the nature of their lesions and the treatment. No studies have been done to understand this difference in the perception of surgery.
Ana Morelló‐Vicente, Inés Oteiza‐Rius, Elisa María Gómez‐González, Ane Carrera‐Gabilondo, Deiane Marcos‐Muñagorri, Mónica María Fernández‐Álvarez, Rafael Salido‐Vallejo   +6 more
wiley   +1 more source

Caninized PD-1 monoclonal antibody in oral malignant melanoma: efficacy and exploratory biomarker analysis. [PDF]

J Immunother Cancer
Igase M, Hagimori K, Inanaga S, Mizoguchi H, Itamoto K, Sakurai M, Motegi T, Yamamoto H, Kato M, Shiga T, Tsukui T, Kobayashi T, Mizuno T.   +12 more
europepmc   +1 more source

Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases. [PDF]

Vet Comp Oncol, 2021
Giacobino D, Camerino M, Riccardo F, Cavallo F, Tarone L, Martano M, Dentini A, Iussich S, Lardone E, Franci P, Valazza A, Manassero L, Del Magno S, De Maria R, Morello E, Buracco P.   +15 more
europepmc   +1 more source

Current state of medical care for patients with mycosis fungoides and Sézary syndrome at a German university hospital – a cross‐sectional study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Studies on the state of medical care for patients with cutaneous T‐cell lymphoma (CTCL) are limited. To date, only secondary data analyses are available for Germany. Patients and Methods Cross‐sectional study conducted over a one‐year recruitment period (01 March 2024 to 28 February 2025) in the dermatological department of a German ...
Inga Hansen‐Abeck, Larissa Kölln, Finn Abeck, Glenn Geidel, Stefan W. Schneider, Nina Booken   +5 more
wiley   +1 more source

Oral Malignant Melanoma Achieving Long-Term Survival With Nivolumab Monotherapy Following Surgical Treatment: A Report of a Rare Case. [PDF]

Cureus
Kobayashi S, Todoroki K, Matsuo K, Abe Y, Kusukawa J.   +4 more
europepmc   +1 more source

Evaluating the Impact of Elective Nodal Irradiation for Dogs With Oral Malignant Melanoma Undergoing Hypofractionated Radiotherapy. [PDF]

Vet Comp Oncol
Gualtieri P, Group L, Ruslander DM, Nolan MW, Boss MK.   +4 more
europepmc   +1 more source

The First Application of Nanoelectrochemotherapy in Feline Oral Malignant Melanoma Treatment-Case Study. [PDF]

Animals (Basel), 2020
Tunikowska J, Antończyk A, Rembiałkowska N, Jóźwiak Ł, Novickij V, Kulbacka J.   +5 more
europepmc   +1 more source